Twenty-two patients with shock complicating myocardial infarction were studied hemodynamically and, despite pharmacologic therapy and regulation of intravascular volume, 16 (73%) subsequently expired. Pulmonary artery end-diastolic pressure (PAEDP) or left ventricular end-diastolic pressure (LVEDP) was > 15 mm Hg in 18 of the 22 patients, and cardiac index (CI) was <2.3 liters/min/m2 in 17 of 22 patients. Fourteen of the 18 patients with PAEDP or LVEDP > 15 mm Hg expired, while two of the four patients with a PAEDP or LVEDP < 15 mm Hg survived. Thirteen of 15 individuals with a CI < 2.3 liters/min/m2 died, and four of seven with a CI > 2.3 liters/min/m2 survived. A ventricular gallop (S.) was audible in 15 patients with PAEDP or LVEDP varying from 13 to 60 mm Hg. In 11 patients with an S, who expired, the PAEDP or LVEDP ranged from 22 to 60 mm Hg. Mean peripheral vascular resistance was 41.3 units in survivors and 67.8 units in nonsurvivors. Six of eight patients who did not survive the period of hospitalization had a depressed response to dextran infusion manifested by a greater increase in PAEDP or LVEDP than in CI.
gnosis Phlebotomy
Ventricular gallop advances have been made in reducing hospital mortality due to the disturbances of primary rhythm attending acute myocardial infarction. Cardiogenic shock, the syndrome of hypotension and peripheral circulatory insufficiency which develops in 10 to 15% of patients hospitalized after myocardial infarction now represents the single most important cause of death in patients admitted to coronary care units." 2 The management of cardiac and circulatory failure by pharmacologic intervention and the availability of mechanical circulatory support devices require hemodynamic quantification of left ventricular dysfunction in shock associated with myocardial infarction, and the definition of physiologic parameters xx hich might identify iml-pending pump failure or circulatory collapse.
Our study concerns the hemodynamic evaluation of 22 individuals who developed cardiogenic shock as a complication of acute myocardial infarction. In each instance intravascular monitoring was undertaken to (1) measure left ventricular performance, (2) provide continuous monitoring of selected hemodynamic parameters, and (3) assess left ventricular function prior to and subsequent to various therapeutic interventions. The hemodynamic measuremeents obtained were uised both to evaluate the response to these interventions and to identify physiologic parameiters carrying prognostic significance.
Methods

Selection of Patients
Tweinty-two patienits with shock complicatiing acute myocardial infarctioni were admitted to the Mlyocardial Infaretion Research Unit (MIRU) of the University of Alabama Hospital anid subsequentlv underweint hemodyvnamic evaluationi. The clinical diagnosis of shock was made wlhen a patient had a cuff systolic blood pressure of 90 mm Hg or less (or 80 mm Hg less thani prior basal levels in a knowni hvpertensive) that was confirmed bv intIraaIrterial catlheterizatioin, was not attributable to arrhvthmias or to transienit hypotension related to medications, and wvas accompanied by otlher signs of shock. These were depressed mentatioin, peripheral vasoconistirictio (pallor, cool, clammy skin ), anid diminiished urinary output (less than 20 cc per hour). The presence of gallop heart sounids on admissionv was confirmed by a senior attenidinig aind by one or more other physicians.
The diagnosis of acute mvocardial infaictioin wxas established from an appropriate history and clinical picture in association wvith electrocardiographic evidence of either transmural or subendocardial cardiac infarction. The development of diagnostic pathologic Q waves and evolutionarv changes in the S-T segment and T waves wvith associated serial enzyme changes (CPK, SGOT, or LDH, or all three) were required for the diag-n2osis of transmural infaretion. Subeiidocardial infaretion wvas diagnosed from finding evolutionarv S-T-segment and T-wave chainges wvith associated serial enizyme changes.
All patients were studied at, or within 16 hours of, the onset of the clinical syndrome of shock and after informed conisent xx as obtainied friom the patienit or familv (in accoraclaiee xwith the Declarationi of Helsinki8) Procedures All investigations xvere perfourmied in a speciallx, equipped room wvhile Usinlg a special bed xvith a radiolucent top xvhich could be turned 90 to the clhassis of the bed so that a ceilinig-mounited Carm fluoroscope had access to the patienit's torso. Right Phasic and mean pressures wvere transduced by Stathain P23Db strain--gauge manometers mounted on a molded-leucite saddle wvhich xvas placed on the patient's arm. These were amplified anid displayed on a multichannlel direct-wiviting recorder (Honey. well V'isacorder). The zero reference xsxas mi-arked at the midehest level. Pulmonarv aIrterial aind left venitricular or central aortic pressures wvere measured in the 22 patienits in wxhom hemodvnamic studies were performed. Left ventricular end-diastolic pressure (LVEDP) wvas measured 0.05 sec after the onset of the QRS complex4 in five patienits, and pulmoniarv arterial end-diastolic pressure (PAEDP ) wvas meastured in 17 patieints.-7 Cardiac outputs wvere determinied by ani indicator-dil-utioni technic usinlg indoeyaninie green injected inlto the pulmonary. ar-terial cathleter with sampling fr-om the left venitrictular or cenltral aortic catlheter; approximationis of the injectioni and sampling sites were uised to obtain valid measturemenits. 8 ,ug/ml), norepinephrine (16 to 32 ,ll/ml), and isoproterenol (2 ug/ml) were infused at a rate necessary to maintain systolic blood pressure between 90 mm Hg and 110 mm Hg. Digoxin was administered in bolus intravenous injections of 0.25 to 0.75 mg. Sympathomimetic therapy for cardiogenic shock was not withheld prior to hemodynamic study when clinically indicated, but none of the patients studied was supported by sympathomimetic amines or digitalis at the time of baseline studies or during studies using volume augmentation.
Left ventricular stroke work (LVSW) in g-m/m2 was calculated from the formula:
where MSP is mean systolic pressure, PAEDP is pulmonary artery end-diastolic pressure, LVEDP is left ventricular end-diastolic pressure, and SI is stroke volume corrected for body surface area. Patients twith ventricular gallop (S,). In all instances S as associated with PAEDP or LVEDP greater than 12 mm Hg. A 100% mortality occurred among patients wcith PAEDP or LVEDP greater than 28 mm Hg (shaded area) regardless of the cardiac index, and eachi of these patients had an S, Closed symbols=nionlsumu-civor.s; open symbolsstrvivors; triangles itnferior infarction; circles anterior infarctioni. Samre symbols also uised in figures 2 and 3. current hospitalization, and five had been hospitalized previously for acute myocardial infarction. Ten patients gave a history of systemic hypertension, six of diabetes mellitus, and nine of congestive heart failure of varying degree.
Sixteen patients manifested electrocardiographic evidence of anterior myocardial infarction, five of inferior myocardial infarction, and one of anterior subendocardial infarction. Only three of 16 patients with anterior infarction survived (18.8%). Two of the five patients with inferior infarction and the patient with subendocardial infarction also survived their hospital course. Of 14 patients developing shock in the 24 hours following myocardial infarction, 11 did not survive hospitalization. Five of the eight patients developing shock more than 24 hours after inyocardial infarction also expired. The overall survival of the group of 22 patients was 27.3%.
Intraventricular conduction defects were noted in seven patients with anterior infarction and in one patient with inferior infarction. An atrial gallop (S4) was noted in seven patients with anterior infarction, in one with inferior infarction, and in the patient with subendocardial infarction. A ventricular filling sound (S.) was heard in 12 of the 16 patients with anterior infarction and in three of the five patients with inferior infarction. S.. was always associated with LVEDP or PAEDP greater than 12 mm Hg ( fig. 1 ).
Baseline Hemodynamic Studies
Baseline hemodynamic measurements for the 22 patients studied are contained in table 4 .0 PAEDP or LVEDP was greater than 15 mm Hg in 15 of the 16 patients with anterior infarction and in three of the five with inferior infarction. PAEDP or LVEDP of more than 28 mm Hg was associated with 100% mortality. Baseline cardiac indices ranged from 0.9 to 3.1 liters/min/m2 (mean, 1.9 liters/min/m2) and were 2.3 liters/min/m2 or lower in 12 of the 16 LV FUNCTION IN SHOCK infusion. In three patients a second infusion of dextran was given within 24 hours of the initial study ( fig. 4 ). In 13 of 15 studies, the intravenous infusion of low molecular weight dextran produced an increase in both cardiac index and PAEDP or LVEDP. In patient 8, PAEDP increased without a concomitant change in cardiac index, and in patient 15 cardiac index decreased without associated change in PAEDP. Peripheral vascular resistance decreased during each of the 15 studies of intravenous infusion of low molecular weight dextran (mean, 13.6 units, P < 0.002). This decrease resulted from an increase in cardiac index unaccompanied by a concomitant increase in mean systolic pressure. Left ventricular minute work increased in 12 of 15 studies but was unchanged or depressed in three other studies. Survivors uniformly responded to volume augmentation with a proportionately greater rise in cardiac output than in PAEDP or LVEDP. Those not surviving tended to manifest a lower baseline cardiac index ( < 1.8 liters/min/m2 with the exception of patient 15) and a higher baseline PAEDP or LVEDP or both (> 19 mm Hg). Exceptions were patients 6 and 12. Nonsurvivors exhibited a proportionately greater increase in PAEDP or LVEDP than in cardiac index with dextran infusion.
Symp)athomimetic Amines
The effect of intravenous infusion of sympathomimetic amines was studied in 10 patients. Preparations used included norepinephrine, epinephrine, and isoproterenol. Epinephrine in patient 2 produced no significant change in either cardiac index (2.3 to 2.4 liters/min/m2) or PAEDP. Norepinephrine, given to three patients, increased peripheral vascular resistance in all three. In patients 6 and 15 variable increases in systemic arterial pressure and systolic left ventricular minute work were observed, but in patient 3 these parameters decreased after the administration of norepinephrine. In patients 6 and 15 cardiac index was unchanged or slightly increased in association with an increase in PAEDP or LVEDP, Circulation, Volume XLV, January 1972 and in patient 3 cardiac index fell. In patient 15 norepinephrine initially produced a fall in PAEDP or LVEDP without a change in cardiac index. Isoproterenol produced an increase in cardiac index in six of six patients and a fall in PAEDP or LVEDP in five of six patients. A fall in peripheral vascular resistance and a rise in left ventricular minute work usually followed isoproterenol.
Digoxin
Intravenous digoxin was given to seven patients who had not previously been taking this medication, and an average increase in cardiac index of 0.150 liters/min/m2 was observed although individual responses varied. In five of the seven patients PAEDP or LVEDP was reduced after the intravenous administration of digoxin, and in two patients this parameter remained essentially unchanged. Changes in peripheral vascular resistance 30 to 40 minutes after digoxin administration were variable, an increase being observed in four patients, a decrease in three. Left ventricular minute work increased in patients 1, 5, 8, 20, and 21, remained unchanged in patient 11, and decreased in patient 22.
Phlebotomy
The hemodynamic response to a phlebotomy of 200 to 400 ml of whole blood was measured in four patients. Variable changes in cardiac index were observed, and PAEDP or LVEDP decreased in three patients.
Discussion
Our investigation into the hemodynamic changes accompanying acute myocardial infarction substantiated earlier findings9 that in seriously ill patients the most frequent cardiovascular abnormalities were a reduction in cardiac output, primarily in stroke volume, and an increase in total peripheral resistance, heart rate, central venous pressure, and left ventricular end-diastolic pressure.'0-The severity of the complications attending myocardial infaretion were related to depression of cardiac pump performance, and the most marked and persistent reductions in cardiac output and stroke volume were found in those individuals with the clinical syndrome of shock who did not survive hospitalization. Within each group of patients studied, however, were critically ill individuals whose hemodynamic profiles did not conform to this general pattern.
Further investigations have described varied hemodynamic patterns which are associated with hypotension accompanying myocardial infarction.6c 7-'21 Systemic hypotension associated with the clinical syndrome of shock is invariably accompanied by reduced cardiac output, but depressed cardiac output is not necessarily accompanied by clinical shock. In some patients systemic hypotension may occur without associated changes in heart rate and with normal or decreased peripheral vascular resistance. In hypotensive states attended by low peripheral vascular resistance, cardiac outputs may be only mildly depressed, normal, or elevated. This range of regional perfusion patterns associated with hypotension suggests that factors regulating systemic vascular resistance are important in the initiation or persistence of cardiocirculatorv insufficiency and that reflex vasoconstrictor mechanisms may be significantly altered in certain individuals. Myocardial ischemia 22 and increased tension in the ventricular wall3 have both been shown to affect heart rate and peripheral vascular tone in such a paradoxical fashion.
The early identification of the patient with shock complicating myocardial infarction and the definition of his hemodynamic status and the hemodynamic parameters which may be continuously monitored are important in guiding the selection and assessment of therapeutic interventions and in assessing prognosis. The monitoring of PAEDP or LVEDP is important in the quantification of left ventricular dysfunction in the patient with cardiogenic shock. In the absence of pulmonary vascular and mitral valvular disease, PAEDP has been shown to accurately reflect LVEDP.5 6 Even in the presence of pulmonary vascular disease, changes in PAEDP may reflect changes in LVEDP more accurately than do changes in central venous pressure.6' 24 The acute hypoxia and acidosis accompanying hypotension associated with myocardial infarction may, hovever, have selective and independent effects upon PAEDP or LVEDP or both. In addition, the influence of a reduced cardiac output on the hepatic and renal metabolism of sympathomimetic amines employed to support patients wvith cardiogenic shock prior to and during investigative study may selectively influence measurements of left ventricular performance.
In the present series of patients with myocardial infarction shock wvas associated with anterior myocardial infarction inore often than with inferior myocardial infarction. Although this may reflect a higher incidence of anterior infarction with a similar incidence of cardiogenic shock in both anterior and inferior infaretion,'25 the higher morbidity attending anterior infarction26 2' seems to indicate a real increased frequency of hemodynamic complications.
Of those patients surviving hospitalization, three had anterior infaretions, txvo inferior infarctions, and one anterior subendocardial infarction. Although the three patients with anterior infarction and one of the tvo with inferior infarction had an elevated LVEDP or PAEDP, they had only slightly depressed cardiac indices and normal or near-normal peripheral vascular resistance. The patient with anterior subendocardial infarction demonstrated a reduced cardiac index associated wvith low PAEDP and near-normal systemic vascular resistance and exhibited marked cardiovascular improvement with the infusion of low molecular weight dextran. A ventricular filling sound (S3) was audible in 15 of the 22 patients and was invariably associated with a PAEDP or LVEDP of 12 mm Hg or greater. In 12 of these 15 patients the cardiac index was 2.4 liters/min/m2 or less and in only one was the stroke index greater than 27 ml. Eight patients, each of wvhom had an S3, had PAEDP or LVEDP greater than 28 mm Hg, and all expired.
Baseline measurement of cardiac and stroke indices demonstrated higher mean values in Circulation. VolunZ e XLV. Januzary 197I2 136 LV FUNCTION IN SHOCK those who survived hospitalization (2.2 liters/min/m2 and 24.2 ml, respectively) than in nonsurvivors (1.7 liters/min/m2 and 16.4 ml, respectively). However, measurements in the two groups overlapped enough to preclude consideration of either of these indices as a prognostic indicator. Systemic vascular resistance demonstrated far less overlap between survivors and nonsurvivors. Normal or near-normal values for peripheral vascular resistance appeared to correlate well with survival. Nonsurvivors tended to have higher values for peripheral vascular resistance.
Previous investigation has attributed prognostic significance to values of left ventricular minute work of less than 3 kg-m/min as being capable of predicting mortality with 95% accuracy.28 Although mean values for left ventricular minute work were slightly higher in survivors than in nonsurvivors (2.0 kgm/min and 1.7 kg-m/min, respectively), this parameter did not predict mortality as accurately in the present group of patients.
The monitoring of cardiac index and PAEDP or LVEDP provides a guide for pharmacologic intervention in the management of shock complicating myocardial infaretion. In the present study the effects of sympathomimetic amines were assessed by continuous hemodynamic monitoring which aided in the selection and cautious administration of these agents in an effort to improve cardiac performance. Norepinephrine and epinephrine produced variable changes in hemodynamic status. While isoproterenol produced an increase in cardiac output in six of six patients and a decrease in PAEDP or LVEDP in five of six patients, five of six patients who received this medication subsequently expired. These findings confirm previous observations that apparent hemodynamic improvement in patients with myocardialinfarction shock receiving this agent is not only transient but is associated with undesirable cardiac metabolic and long-term hemodynamic deterioration.29
Studies to date have been unable to demonstrate significant improvement in cardiac output in the acute phase of myocardial Circulation, Volume XLV, January 1972 infarction following the administration of digitalis.30 31 Intravenous digoxin in seven of our 22 patients did not produce statistically significant changes in PAEDP or LVEDP, cardiac index, or external cardiac work.
Myocardial performance may be assessed by relating stroke index, cardiac index, or left ventricular work to PAEDP or LVEDP.7 Severe left ventricular dysfunction and a grave prognosis accompany hypotension associated with depressed cardiac output and elevated PAEDP or LVEDP. From among these patients with myocardial-infaretion shock, a group may be identified with depressed cardiac outputs and low PAEDP or LVEDP in whom either paradoxical peripheral vasodilatation (functional hypovolemia) or true hypovolemia contributes to hypotension. Hypovolemia has been reported as a complication in 20% of patients with cardiogenic shock.32 In such patients the rapid infusion of dextrose or low molecular weight dextran increases cardiac output without elevating central venous pressure.21' 33, 3 Some patients with apparently normal cardiac function secondary to intense vasoconstriction may benefit from volume augmentation.33 In the experimental animal a hyperosmolar solution has been shown to result in beneficial changes during myocardial ischemia.35 In the present study the responses to dextran infusion may have derived from an increase in preload and a decrease in afterload as well as from the position of the particular ventricle on its function curve.
The infusion of low molecular weight dextran into patients with an initial PAEDP or LVEDP of 30 mm Hg or less aided in identifying those who responded favorably to medical management. When ventricular performance was assessed by plotting stroke index, cardiac index, or left ventricular stroke work against PAEDP or LVEDP, survivors uniformly responded to augmentation of intravascular volume with a proportionately greater increase in cardiac index than in PAEDP or LVEDP. Nonsurvivors tended to have a lower cardiac index or a higher left ventricular filling pressure or both at the time 137 of study and generally demonstrated a depressed response to volume expansion manifest by a proportionately greater increase in PAEDP or LVEDP than in cardiac index. Those responding to volume expansion with improved cardiac performance had baseline cardiac indices of 1.8 liters/min/m2 or more (with the exception of patient 16) and PAEDP or LVEDP of 20 mm Hg or less prior to dextran infusion.
The hemodynamic monitoring of cardiac index and PAEDP or LVEDP and of the response to volume -augmentation by low molecular weight dextran appears to carry prognostic significance. From patients with shock subsequent to myocardial infarction, individuals were identified with hemodynamic parameters and characteristic trends that correlated with 100% mortality. Such individuals did not benefit from intensive medical management, tended to have cardiac indices of less than 2.3 liters/min/m2 in association with PAEDP or LVEDP of 15 mm Hg or greater, and the majority demonstrated a depressed response to augmentation of intravascular volume. Similarly, those patients with PAEDP or LVEDP greater than 28 mm Hg did not survive hospitalization. Early identification of patients within these groups will allow more aggressive therapeutic intervention, in the form of mechanical circulatory assistance and coronary artery bypass surgery during the acute stages,36 which may alter a uniformly grave prognosis.
